Skip to content

Opaleye Management Inc., 10% owner at Eton Pharmaceuticals, sold ETON on Jul 2, 2026

Data as of Oct 16

▼ SELL$2.4M65,000 shares at $37.39Opaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.
Watch ETON
Traded
Jul 2, 2026
Disclosed
Jul 7, 2026
Filed
5 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Opaleye Management Inc., 10% owner at Eton Pharmaceuticals, sold ETON on Jul 2, 2026TRADEDDISCLOSED
ETONSimilar stocks (XLV — its sector index fund), rebased to ETON's price on the disclosure day
ETON since disclosure
+33.3%
after the sale
Similar stocks (XLV) since disclosure
+7.5%
XLV — its sector index fund

Change in closing price from Jul 7, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$767Kdisclosed Jul 7 · filed the same day
  2. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$257Kdisclosed Jul 7 · filed the same day
  3. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$380Kdisclosed Jul 7 · filed 1 day after the trade
  4. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$935Kdisclosed Jul 7 · filed 5 days after the trade · late

See every trade on ETON →